mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.16 |
0.01 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.15 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |